IFP Advisors’s bioAffinity Technologies BIAF Stock Holding History
Bought
Maintained
Sold
Other funds holding BIAF
IFP Advisors's BIAF Position: Q3 2026 in Review
IFP Advisors increased its bioAffinity Technologies (BIAF) stake by 1,486% in Q3 2026, buying an estimated $7.19K and bringing the position to 888 shares worth $694. The position accounts for ﹤0.01% of the portfolio, ranked #4591.
IFP Advisors first reported a position in BIAF in Q4 2023 and has held it in 12 quarters since. The position peaked at $21.6K in Q2 2024. 5 funds tracked by Wall St. Rank hold BIAF as of Q3 2026.
- IFP Advisors held 888 shares of bioAffinity Technologies worth $694 as of Q3 2026.
- IFP Advisors bought 832 bioAffinity Technologies shares in Q3 2026, an estimated $7.19K.
- bioAffinity Technologies made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4591 holding.
- IFP Advisors first reported a position in bioAffinity Technologies in Q4 2023 and has held it in 12 quarters since.
- IFP Advisors's bioAffinity Technologies position peaked at $21.6K in Q2 2024.
- 5 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.